Recombinant CD19 (Tafasitamab Biosimilar) anticorps

N° du produit ABIN7675648

Cet anticorps Human Monoclonal détecte spécifiquement CD19 (Tafasitamab Biosimilar) dans ELISA, BLI, FACS, Func et SPR. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant CD19 (Tafasitamab Biosimilar) anticorps (ABIN7675648)

Antigène: CD19 (Tafasitamab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CD19 (Tafasitamab Biosimilar) est non-conjugé

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-CD19 (Tafasitamab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CD19 Reference Antibody (tafasitamab)

Séquence: EVQLVESGGG LVKPGGSLKL SCAASGYTFT SYVMHWVRQA PGKGLEWIGY INPYNDGTKY NEKFQGRVTI SSDKSISTAY MELSSLRSED TAMYYCARGT YYYGTRVFDY WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG GPDVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVQFN WYVDGVEVHN AKTKPREEQF NSTFRVVSVL TVVHQDWLNG KEYKCKVSNK ALPAPEEKTI SKTKGQPREP QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP MLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K,DIVMTQSPAT LSLSPGERAT LSCRSSKSLQ NVNGNTYLYW FQQKPGQSPQ LLIYRMSNLN SGVPDRFSGS GSGTEFTLTI SSLEPEDFAV YYCMQHLEYP ITFGAGTKLE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

Attributs du produit: Anti-CD19 Reference Antibody (tafasitamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.56 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: CD19 inhibitors, ADCC, Antibody-dependent phagocytosis

Conditions: Acute lymphoblastic leukemia Acute myeloid leukemia Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Non-Hodgkin's Lymphoma

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur CD19 (Tafasitamab Biosimilar)

Antigène: CD19 (Tafasitamab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 144.56 kDa

UniProt: P15391